Kora Saúde Participações S.A. (BOVESPA:KRSA3) agreed to acquire IDE diagnostics clinic in Serra for BRL 14 million on January 24, 2022. The total cash consideration of which BRL 12 million will be paid upon conclusion of the operation and the rest is to be paid within five years.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 BRL | +14.67% | +13.16% | -33.85% |
Feb. 28 | Transcript : Kora Saúde Participações S.A., Q4 2023 Earnings Call, Feb 28, 2024 | |
Feb. 27 | Kora Saúde Participações S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.85% | 129M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+9.72% | 10.79B | |
-2.19% | 7.68B | |
+18.43% | 7.2B | |
+4.49% | 6.67B | |
+50.89% | 4.66B | |
-5.12% | 4.25B |
- Stock Market
- Equities
- KRSA3 Stock
- News Kora Saúde Participações S.A.
- Kora Saúde Participações S.A. agreed to acquire IDE diagnostics clinic in Serra for BRL 14 million.